
Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
14/1/2026
0:00
7:39
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Altri episodi di "TechCrunch Startup News"



Non perdere nemmeno un episodio di “TechCrunch Startup News”. Iscriviti all'app gratuita GetPodcast.







